Trial Details

Not Recruiting
Basic Information
Clinical ID c3327
Identifier ACTRN12608000260325
Trial Title Immunogenicity of Human papillomavirus vaccine in immunosuppressed children
Trial URL Visit Original Page
Study Information
Study Results

Yes

Conditions Human papillomavirus (HPV); Human papillomavirus (HPV);Cancer - Cervical (cervix)
Interventions Site One Three doses will be given; the first will be given at 6-12mths post transplant for bone marrow transplant patients and pre-transplant for liver transplant patients. Patients with Inflammatory bowel disease will receive it at enrolment. The second vaccination will be given in 2 months post the first vaccination. The third dose will be 4 months post the second visit (6 months from the first vaccine). Site Two Three doses will be given, the first will be given at enrolment for patients with rheumatic disease such as juvenile idiopathic arthritis (JIA) and systemic lupus erythematosus (SLE). The second vaccination will be given in 2 months post the first vaccination. The third dose will be 4 months post the second visit (6 months from the first vaccine). At both sites The vaccines will be given in the non-dominant arm by a trained and experienced paediatric immunisation nurse Dose: Three 0.5 mL doses of Gardasil (registered product)
Participant Information
Sponsor The Children's Hospital at Westmead
City -
Country/Region Australia
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, CHILD, TEENAGER
Study Design
Study Type Interventional
Phase Not Available
Time Information
Start Date 2025-04-24
Primary Completion Date 2019-11-22
Completion Date 2016-02-03